Magnetic Resonance in Children With TM
further open the prognosis in this population. Unfortunately, data about this issue are scarce and not definitive. 6, 7 The highly sensitive and reproducible magnetic resonance imaging (MRI) T2* technique has revolutionized thalassemia management, 8 providing a direct assessment of cardiac and hepatic iron content and evaluating the effectiveness of iron chelation therapy. [9] [10] [11] The multislice approach [12] [13] [14] detects uneven iron accumulation in the heart and allows to identify patients at risk for cardiac complications in a precocious stage. 15 Moreover, cardiovascular magnetic resonance (CMR) provides the opportunity to quantify bi-atrial and biventricular function parameters with excellent reproducibility. 16 Furthermore, with the same scan, it is possible to acquire late gadolinium enhancement (LGE) images to determine the presence of myocardial fibrosis, which is still unstudied in children affected by TM.
This study aims at a retrospective multiparametric CMR assessment of cardiac iron overload, function, and fibrosis in a cohort of pediatric patients with TM enrolled in a large cooperative study, including >2000 patients with hemoglobinopathies.
Methods

Study Population
From the 2171 patients with hemoglobinopathies enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) Network, we retrospectively selected 107 pediatric TM patients (age <18 years) who had undergone at least 1 MRI scan.
The MIOT Network is constituted by 9 MRI sites and 70 thalassemia centers where CMR exams are performed using standardized and validated procedures and where patients' clinical-instrumental data are put in a centralized database via web. 17 The patients were monitored for glucose dysregulation according to the current Thalassaemia International Federation (TIF) Guidelines at the time of the study. 18 Even if the fasting plasma glucose was normal, all patients performed an oral glucose tolerance test at the age of puberty.
The study complied with the Declaration of Helsinki. Parents gave their informed consent for all patients. The project was approved by the institutional ethics committee.
MRI
MRI was performed using a 1.5T scanner (GE Excite HD). An 8-element cardiac phased array receiver surface coil and ECG gating was used.
For the measurement of myocardial iron overload (MIO), a multislice multiecho T2* approach was adopted. 12 Three parallel short-axis views (basal, medium, and apical) of the left ventricle (LV) were obtained by T2* gradient-echo multiecho sequence. Each short axis was acquired at 9 echo times in a single end-expiratory breath-hold. 12, 19, 20 For the measurement of liver iron overload, a T2* gradient-echo multiecho sequence was used. A single transverse slice through the liver was obtained at 9 echo times in a single endexpiratory breath-hold.
21 T2* image analysis was performed using a previously validated software (HIPPO MIOT). 20, 22 The software provided the T2* value on each of the 16 segments of the LV according to the standard American Heart Association/American College of Cardiology model, as well as the global T2* value averaged over all segmental values and the T2* value in the midventricular septum averaged over the mid-anterior and inferior septum. A T2* measurement ≥20 ms was taken as conservative normal value for all 16 segments and for the global T2* value. 8, 20, 23 T2* values were converted into cardiac iron concentration by using the formula introduced by Carpenter. 23 The conservative cut-off corresponds to a cardiac iron concentration ≥1.16 mg/g/dw.
For the liver, the T2* value was calculated in a large region of interest of standard dimension, chosen in a homogeneous area of parenchyma. 17, 21, 24 A liver T2* value <9.2 ms was considered indicative of a significant load. Using the calibration curve introduced by Wood, 25 this cut-off corresponds to a liver iron concentration (LIC) ≥3 mg/g/dw. 6, 26 Following the thresholds proposed by Angelucci et al, 26 severe liver iron overload was considered present with a LIC >14 mg/g/dw (T2* value <1.8 ms).
Steady-state free procession cines were acquired during 8-second breath-holds in sequential 8-mm short-axis slices from the atrio-ventricular ring to the apex to assess biventricular function parameters quantitatively in a standard way, 27 using MASS software (Medis, Leiden, The Netherlands). Views-per-segment were adjusted according to the heart rate. End-diastolic volume, end-systolic volume, stroke volume, and ejection fraction were measured for both the ventricles. The LV mass was also evaluated. Except for ejection fraction, indices of these parameters were calculated by the adjustment of body surface area. LV or right ventricular (RV) dysfunction was diagnosed in the presence of an ejection fraction <2 standard deviations (SD) from the mean value normalized to age and sex. 28, 29 The intercenter variability for the quantification of cardiac function had been previously reported. 30 Left and right atrial areas were measured from the 4 chamber view projection in ventricular end-systolic phase.
LGE images were acquired in the same view used for cine cardiac MRI from 10 to 18 minutes using a fast gradient-echo inversion recovery sequence. The contrast medium gadopentate dimeglumine (Magnevist; Bayer Schering Pharma; Berlin, Germany; 0.2 mmoli/ kg) was intravenously administrated.
LGE was considered present if visualized in 2 different views. The extent of LGE areas was quantified using a previously validated software. 4, 31 In thalassemia, the LGE technique was proved to be safe.
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Statistical Analysis
All data were analyzed using SPSS version 13.0 statistical package.
The normality of distribution of the parameters was assessed by using the Kolmogorov-Smirnov test.
Continuous variables with normal distribution were described as mean±SD, whereas non-normal variables were represented with median and 25th and 75th percentiles.
Categorical variables were expressed as frequencies and percentages.
For continuous values with normal distribution, comparisons between groups were made by independent-samples t test (for 2 groups) or 1-way analysis of variance (for >2 groups). Wilcoxon's signedrank test and Kruskal-Wallis test were applied for continuous values with non-normal distribution. The Bonferroni adjustment was used in all pairwise comparisons. χ 2 testing was performed for noncontinuous variables.
Analysis of covariance models were used to evaluate the impact of cardiac iron on the relationship between myocardial fibrosis and cardiac remodeling. When necessary, outcomes were log-transformed to normalize the residual distributions and to equalize the residual variance.
Correlation analysis was performed using Pearson's test or Spearman's correlation where appropriate. Odds ratios and 95% confidence intervals were calculated.
To determine the best serum ferritin and LIC cut-offs for discriminating the presence and absence of MIO, the maximum sum of sensitivity and specificity was calculated from receiver-operating characteristic curve analysis.
A 2-tailed probability <0.05 was considered statistically significant.
Results
Patient Data
One hundred and five patients were Italian, whereas 2 had recently arrived in Italy from South America. Age range was 4.2 to 17.9 years.
At the first MRI examination, the 2 patients from South America were not chelated. Magnetic Resonance in Children With TM Clinical data are summarized in Table 1 .
CMR Data
MRI data are summarized in Table 2 .
All MRI scans were performed without sedation. No significant correlation was found between global heart T2* values and age (r=0.022; P=0.823) or sex (P=0.288).
Global heart T2* values were significantly associated to midseptum T2* values, but the bias between the 2 measurements increased for values >20 ms ( Figure 1) .
Twenty-three patients (21.5%) showed an abnormal global heart T2* value, and none of them was under 7.9 years of age ( Figure 2A ).
Serum ferritin was negatively correlated with global heart T2* values (r=-0.425; P<0.0001). Using receiver-operating characteristic curve analysis, a serum ferritin of 2000 ng/mL was found to be the best threshold for discriminating the presence of cardiac iron with an area under the curve of 0.733 (P=0.001; Figure 3A ). Odds ratios for global heart T2* values <20 ms was 3.9 (1.2-12.5 95% confidence intervals; P=0.023) for serum ferritin ≥1500 ng/mL and 4.9 (1.7-13.8 95% confidence intervals; P=0.003) for serum ferritin levels ≥2000 ng/mL.
There was a significant negative correlation between global heart and MRI LIC values (P=−0.436; P<0.0001). Using receiver-operating characteristic curve analysis, an LIC ≥14 mg/g/dw was found to be the best threshold for discriminating the presence of MIO in children with an area under the curve of 0.817 (P<0.0001; Figure 3B ). Odds ratios for abnormal global heart T2* values was 30.08 (3.58-252.68 95% confidence intervals; P=0.002) for patients with MRI LIC ≥14 mg/g/dw versus patients with normal MRI LIC. Out of the 23 patients with an abnormal global heart T2* value, 22 showed hepatic iron overload (1 mild, 4 significant, and 17 severe), and 1 had a T2* value close to the cut-off (2.9 mg/g/dw).
No significant correlations were found between the global heart T2* values and the biatrial areas or the LV and RV functional parameters, with the exception of the RV systolic volume index (r=−0.232, P=0.016). Eighteen patients (16.8%) showed LV dysfunction. Of them, 6 (33%) had a global heart T2* value <20 ms (Figure 2A ). LV dysfunction was present in the youngest patient involved in this study (a girl of 4.9 years who did not receive any chelation treatment). Excluding this patient, none of the patients with LV dysfunction was under 6.6 years of age. Eight patients (7.5%) showed RV dysfunction. Of them, one (12.5%) had a global heart T2* value <20 ms. None of the patients with RV dysfunction was under 11.3 years of age.
No difference in the chelation regimen was found between the patients with significant heart iron (global heart T2* <20 ms) versus the patients without significant heart iron (P=0.472).
Patients with global heart T2* ≥20 ms had more frequently a good/excellent compliance to the chelation therapy compared with patients with significant cardiac iron (93.9% versus 73.9%; P<0.013). Hemoglobin pretransfusion, g/dL 9.6 (9.4-9. Chelation therapy, n (%) The clinically and instrumentally relevant findings in the 4 groups are summarized in Table 3 . The mean serum ferritin levels in the last year were significantly different between groups A and C (P=0.012 and P=0.030, respectively). The groups C and D had a significantly higher MRI LIC value than the group A (P<0.0001 for both comparisons) and the group B (P=0.030 and P=0.012) .
The left ventricular end-diastolic volume index was significantly higher in the group D than in the groups A and B (P=0.034 and P=0.035), whereas the left ventricular end-systolic volume index was significantly higher in the group D than in the group A (P=0.050). The group D had a significant higher LV mass index than all the other groups (P=0.026 versus group A, P=0.019 versus group B, and P=0.006 versus group C). The right ventricular systolic volume index was significantly higher in the group D than in the group A (P=0.026).
In 31 patients, the presence of myocardial fibrosis was not investigated because the parents did not give the consent to the administration of the contrast medium or because a short MRI protocol was chosen to avoid a sedation.
The youngest patient showing myocardial fibrosis had 13 years of age. No patients showed an ischemic pattern. Table 4 shows the comparison between patients with and without myocardial fibrosis. A significant higher MIO was detected in patients with myocardial fibrosis ( Figure 5 ). The association between myocardial fibrosis and cardiac remodeling persisted also after the correction for global heart T2* values.
Liver MRI Data
No significant correlation was found between MRI LIC values and age (r=0.138; P=0.158). Eighty-three patients (77.6%) showed a pathological MRI LIC ( Figure 2B ). MRI LIC values were not significantly different between boys and girls (P=0.076). Serum ferritin was positively correlated with MRI LIC values (r=0.668; P<0.0001).
No difference in the chelation regimen was found between the patients with liver iron (MRI LIC ≥3 mg/g/dw) versus the patients with no liver iron (P=0.515). 
Discussion
Current life expectancy in TM patients is definitely improved in the last 15 years, mainly thanks to widespread use of MRI for detecting iron overload in target organs (liver and heart).
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Although several studies focused on adults, [8] [9] [10] [11] 33 this is the largest report of TM children undergoing MRI assessment using a multiparametric approach. In rare diseases, collaborative projects like the MIOT Network may be useful to produce evidence that aids better management of patients.
In our series of 107 pediatric TM patients, selected retrospectively from a large cohort of thalassemia patients, sedation was never necessary because the children had been carefully prepared, thanks to the cooperation among family, nurse, and physician.
The pattern of iron loading in TM could be better revealed in children because the kinetics of iron uptake/release in different organs is not altered by multiple comorbidities, medications, or changes in chelators. 9, 19, 34 Furthermore, TM children undergo a more regular transfusion regimen, and the amount of transfused red blood cells tends to be more tailored to body weight; indeed they could represent the ideal population to study the initial stage of iron loading and the onset of its complications.
Our results show that in TM children, iron is initially and mainly stored in liver because the vast majority of assessed patients (77.6%) presented with pathological MRI LIC (the youngest 4.2 years old; Figure 2B ), with moderate to severe liver iron overload in more than half of them (68%).
Only 37.7% of patients showed no MIO (Figure 4) , and the youngest patient with MIO was 7.9-year-old, thus suggesting that children can accumulate iron also in the heart at early age ( Figure 2) . Thus, the first cardiac T2* assessment should be performed as early as possible without sedation, as recently confirmed by other studies focused on TM children younger than 10 years. 6, 7 To our knowledge, this is largest report about iron overload prevalence by MRI in white TM children. TM children patients with a homogenous MIO showed significantly more pronounced signs of negative cardiac remodeling and significantly higher traditional markers of cardiac risk (LIC or serum ferritin). Although nonprospective data are available in pediatric population, our preliminary prospective data on a large cohort of TM adult patients shows that a homogeneous MIO identifies patients at high risk of heart failure. 35 Additionally, a heterogeneous iron overload distribution in the heart, previously demonstrated in TM adults and in TM children <10 years, 6, 15 is now reported also in pediatric patients, and a sizeable part of those with global heart T2* >20 ms experienced heterogeneous iron overload (group B). It has been demonstrated that 20 ms is a conservative cut-off value for T2*. In fact, by T2* calibration data, 20 ms equates to 1.1 mg/g iron dry weight, 23 which is approximately twice the historically reported normal mean level of human myocardial iron. 36 Most of the patients in group B have a global heart T2* in the 20 to 30 ms range corresponding to early cardiac iron overload. In a recently published paper 37 on a large cohort of adult thalassemia major patients, no significant differences were found between patients with no MIO and patients with heterogeneous MIO and global heart T2* >20 ms. However, no-prospective data are available in pediatric population and the segmental analysis results particularly useful in pediatric population to detect iron overload early and to identify borderline patients, who could particularly take advantage of tailoring chelation therapy for preventing iron-related heart damage. The comparison with a contemporary white cohort of TM children <10 years 6 shows clearly that iron burden is a time-dependent process.
In our cohort, a correlation between liver and heart iron was found. In particular, all patients with detectable cardiac iron presented moderate to severe liver iron overload.
Recently, the ability of LIC and serum ferritin in predicting cardiac iron overload is challenged by MRI monitoring, which demonstrated no correlation between serum ferritin or LIC and cardiac iron. 19, [38] [39] [40] To resolve these differences, an interesting hypothesis suggested a delay in cardiac iron uptake, while liver is primarily filled. 41 Our results concur with this hypothesis because an initial connection between hepatic and cardiac iron was demonstrated in our pediatric population where the organ-specific mechanisms of iron loading/unloading are not masked by severe iron overload or intensive chelation. MRI LIC ≥14 mg/g/dw and serum ferritin levels ≥2000 ng/mL were found to be significant risk factors for a global heart T2* value <20 ms in TM children. The role of this traditional markers could result particularly useful in pediatric population, where MRI assessment is difficult to carry out because of early age, scarce collaboration, or limited availability. The weak correlation between heart iron and LIC or serum ferritin confirms that total body iron stores do not have strong predictive value with respect to the presence of cardiac iron. 6 Anyway, when CMR is unavailable, serum ferritin ≥2000 ng/mL and LIC ≥14 mg/g/dw predict presence of cardiac iron overload in children.
Previously, myocardial fibrosis was demonstrated as a relative common finding (≈20%) in Italian TM adults, 4, 5, 42 and now it appears not rare also in TM children. Extensive fibrosis replacement was shown in previous autoptic studies, [43] [44] [45] [46] but little contemporary data investigates the role of myocardial fibrosis in the development of cardiac disease in TM. In adult TM population, myocardial fibrosis has been shown to be correlated with age, HCV infection, and diabetes mellitus, 4, 5 but no relationship has been found with MIO. 4, 42 Our results suggest that in TM children, cardiac iron overload is one of the main determinants of myocardial fibrosis ( Figure 5 ), which could predispose to heart diseases. In fact, the stigmata of negative cardiac remodeling are significantly more represented in TM children with myocardial fibrosis (Table 4 ). As our cohort is a young cohort free of complications (diabetes mellitus or HCV infection), it has been possible to find a significant link between heart iron and replacement myocardial fibrosis. However, the association between myocardial fibrosis and a negative cardiac remodeling persisted also after the correction for global heart T2* values. This datum seems to suggest that when the myocardial fibrosis appears, the risk of a negative cardiac remodeling is independent from the presence of iron. However, CMR LGE can be postponed until 13 years old unless HCV infection or cardiac disease is present.
In conclusion, this is the largest study about TM children using a multiparametric MRI approach. The data presented are indicative of high rate of liver iron overload at early age. TM children can also experience significant MIO with a global heart T2* value <20 ms (21.4%) correlated with lower compliance and traditional markers of cardiac risk, such as serum ferritin ≥2000 ng/mL and MRI LIC ≥14 mg/g/dw. Specifically, a homogeneous pattern of MIO was associated with negative cardiac remodeling indexes and significantly higher LIC. Myocardial fibrosis is not a rare finding correlated with a negative cardiac remodeling, and iron overload is the main determinant in children.
MRI T2* scanning should be recommended as early as feasible without sedation to tailor chelators. Conversely, LGE CMR is indicated in teenagers, particularly in those with cardiac iron. 
